Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy.
about
Modelling co-infection of the cystic fibrosis lung by Pseudomonas aeruginosa and Burkholderia cenocepacia reveals influences on biofilm formation and host responseNonparametric association analysis of bivariate left-truncated competing risks data.Emergent bacteria in cystic fibrosis: in vitro biofilm formation and resilience under variable oxygen conditions.nBioChip, a Lab-on-a-Chip Platform of Mono- and Polymicrobial Biofilms for High-Throughput Downstream Applications.Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients.Macrolides decrease the minimal inhibitory concentration of anti-pseudomonal agents against Pseudomonas aeruginosa from cystic fibrosis patients in biofilmClinical significance of microbial infection and adaptation in cystic fibrosis.Infectious Disease Management through Point-of-Care Personalized Medicine Molecular Diagnostic TechnologiesAdaptation of Pseudomonas aeruginosa in Cystic Fibrosis airways influences virulence of Staphylococcus aureus in vitro and murine models of co-infectionMicrobiome in cystic fibrosis: Shaping polymicrobial interactions for advances in antibiotic therapy.Using bacterial biomarkers to identify early indicators of cystic fibrosis pulmonary exacerbation onsetRapid Detection of Emerging Pathogens and Loss of Microbial Diversity Associated with Severe Lung Disease in Cystic FibrosisA quantitative analysis of Ureaplasma urealyticum and Ureaplasma parvum compared with host immune response in preterm neonates at risk of developing bronchopulmonary dysplasiaEnhancing the utility of existing antibiotics by targeting bacterial behaviour?Bacterial cis-2-unsaturated fatty acids found in the cystic fibrosis airway modulate virulence and persistence of Pseudomonas aeruginosa.Immune modulation by group B Streptococcus influences host susceptibility to urinary tract infection by uropathogenic Escherichia coli.Autoinducer-2 of Streptococcus mitis as a Target Molecule to Inhibit Pathogenic Multi-Species Biofilm Formation In Vitro and in an Endotracheal Intubation Rat ModelStenotrophomonas maltophilia: emerging disease patterns and challenges for treatment.Soil-on-a-Chip: microfluidic platforms for environmental organismal studies.Emperor's new clothes: Is particle disease really infected particle disease?Interactions between Pseudomonas aeruginosa and Staphylococcus aureus during co-cultivations and polymicrobial infections.Insights into Cystic Fibrosis Polymicrobial Consortia: The Role of Species Interactions in Biofilm Development, Phenotype, and Response to In-Use AntibioticsCooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm.Differential response of Streptococcus mutans towards friend and foe in mixed-species culturesPseudomonas siderophores in the sputum of patients with cystic fibrosis.Phenazine content in the cystic fibrosis respiratory tract negatively correlates with lung function and microbial complexity.Combined Application of Bacterial Predation and Violacein to Kill Polymicrobial Pathogenic Communities.Microbial ecology and adaptation in cystic fibrosis airways.The archetype Pseudomonas aeruginosa proteins TssB and TagJ form a novel subcomplex in the bacterial type VI secretion system.Community interactions and spatial structure shape selection on antibiotic resistant lineages.
P2860
Q30394473-3B91BA24-DB14-4EF7-88E7-2D45B3B35C33Q31019408-E0A321B7-52BF-4279-B5C9-3760B0EF4745Q33609099-FD846B7A-3A20-49C3-BD06-20C274B75FD3Q33849725-624F7304-9007-4910-A05C-6DCC23A3CFF7Q34297656-0F7F1A17-B71F-4F13-90E9-CCA580BD31EAQ34408724-3CC72FEE-90EE-4EEA-9969-C3FC02D68D81Q34491552-123601A0-87D0-4081-A8D9-6A1B57FD0D4EQ34608590-C57B144F-D228-4F5B-8B95-80AE729536F2Q35113179-3BAF89CF-BEE8-4AD3-9CB0-48AD0F440C1FQ35124580-B4B1F0AB-4410-4108-981C-10DF291AA536Q35143420-E7604863-A2E7-471D-A421-685A2522CCA0Q35602934-CDC6B9A1-4464-4B9C-A666-C8ACEF72CE07Q35807027-55B3E4AE-4BC1-4EB6-B59A-54F4295DA308Q35853204-718A6689-4C53-4DC9-A129-ABC4BA40D0E4Q35896321-B750DD08-329E-4E60-BED8-22E41BC2E2BFQ36396848-4B15045C-A625-446C-A291-983F2194713EQ36554822-37395456-D37A-4735-8AA2-4712F672EA08Q37866819-CF15C834-E183-4414-8C44-DDC27DB137BDQ38662299-11BBC929-6D6D-4E6C-BDD5-D1989C3A428BQ38833640-C7B2DB14-8663-4C9F-9142-72A52B8E6E01Q38847303-E65883C6-321F-4C03-A26F-B2C407F92663Q38992886-E8BC136B-5E29-47FA-8673-111306993E97Q40964077-13417D49-1EA2-4F18-97AB-9DEEFE87090DQ42058875-6EBBD552-76C1-437D-BE95-D38B6C4BBE4BQ43591682-00275061-FCC1-4993-AB9C-BBFCB7843B79Q45729541-E2EBBD79-5926-4C41-885F-B05E66D805D8Q46271311-914EA78B-A75C-4B6E-BEF3-9580D4E5C0DEQ51173006-930683FB-8E73-476F-AAD2-5548F8AB3782Q53150338-35A495FE-1D07-4BDF-9046-934C662C2931Q55447824-5530C588-E551-488A-9408-9B0CF4B3C4BF
P2860
Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy.
@ast
Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy.
@en
Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy.
@nl
type
label
Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy.
@ast
Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy.
@en
Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy.
@nl
prefLabel
Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy.
@ast
Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy.
@en
Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy.
@nl
P2093
P2860
P1476
Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy.
@en
P2093
Geraint B Rogers
Kenneth D Bruce
Lucas R Hoffman
Mary P Carroll
Thomas W V Daniels
P2860
P304
P356
10.1016/J.TIM.2010.04.005
P577
2010-06-01T00:00:00Z